-
Stocks Gaining Momentum: Seventy Seven Energy (NYSE:SSE), Bank of America (NYSE:BAC), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Paramount Gold and Silver (NYSEMKT:PZG), NVR (NYSE:NVR)
Seventy Seven Energy Inc (NYSE:SSE) reported a rise of 1,236,972 shares or 40.6% in the short interest. The remaining shorts are 8.7% of the total floated shares. The net short interest, as on December 31,2014, stood at 4,285,168 shares and the stocks days to cover will be 2 by factoring in the average per day…
-
Investor’s Choice: Johnson & Johnson (NYSE:JNJ), Matrix Service Company (NASDAQ:MTRX), Nordic American Offshore (NYSE:NAO), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Google Inc (NASDAQ:GOOG)
For more than eight years, Johnson & Johnson (NYSE:JNJ) has pursued billions of dollars in damages against Boston Scientific Corp (BSX.N) after the latter won a controversial – and ultimately ill-fated – bidding war for device maker Guidant. On Wednesday shares of Johnson & Johnson (NYSE:JNJ) closed at $101.90. Company’s sales growth for last 5…
-
Mix Sector Stocks News: U.S. Bancorp (NYSE:USB), Ford Motor Company (NYSE:F), SunEdison (NYSE:SUNE), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Terra Nitrogen Company (NYSE:TNH)
Analysts at Evercore ISI initiated coverage on shares of U.S. Bancorp (NYSE:USB) in a research note on Monday. They set a “hold” rating and a $46.00 price target on the stock. On Friday shares of U.S. Bancorp (NYSE:USB) closed at $41.52. Company’s sales growth for last 5 years was -0.20% and EPS growth for next…
-
Investors Alert: Morgan Stanley (NYSE:MS), General Motors Company (NYSE:GM), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Wabash National Corp. (NYSE:WNC), BB&T Corporation (NYSE:BBT)
Morgan Stanley (NYSE:MS) declared a regular dividend on the outstanding shares. The dividends for the Preferred Stock Series A, C, E, F, G, H and I are payable on January 15, 2015 to stockholders of record at the close of business on December 31, 2014. Morgan Stanley (NYSE:MS) in last trading activity fell -0.23% to…
-
Big Movers: American Realty Capital Properties (NASDAQ:ARCP), BlackBerry Ltd (NASDAQ:BBRY), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Seadrill Partners LLC (NYSE:SDLP), Kosmos Energy (NYSE:KOS)
On 24 December American Realty Capital Properties, Inc. (NASDAQ:ARCP) said that it has received an additional waiver from lenders, as well as an extension for reporting its third-quarter and full-year results for 2014, as the real-estate investment trust continues to deal with the fallout from the revelation of accounting irregularities. American Realty Capital Properties, Inc.…
-
Biotech Unusual Volume: Cerus Corporation (NASDAQ:CERS), Cyclacel Pharmaceuticals (NASDAQ:CYCC), Sorrento Therapeutics (NASDAQ:SRNE), OvaScience (NASDAQ:OVAS), Radius Health (NASDAQ:RDUS)
Cerus Corporation (NASDAQ:CERS) out of Concord, California received FDA approval for its INTERCEPT Blood System for plasma, a product that’s used to prevent infections by treating blood plasma prior to a transfusion. Cerus Corporation (NASDAQ:CERS) in last trading activity moved up 22.59% to close at $5.86. Company weekly performance is 26.84% while its quarterly performance…
-
Mix Sector Stocks News: Cyclacel Pharmaceuticals (NASDAQ:CYCC), Comstock Resources Inc. (NYSE:CRK), Sapiens International Corporation N.V. (NASDAQ:SPNS), Oppenheimer Holdings (NYSE:OPY), IntraLinks (NYSE:IL)
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) on Dec. 16 announced enrollment of 486 patients, continuation to final analysis and recommendations of the independent Data and Safety Monitoring Board (DSMB) of the Company’s Phase 3 SEAMLESS study of oral sapacitabine capsules in acute myeloid leukemia (AML). All patients will continue to be followed up until mature data become…
-
Stock in News: Cyclacel Pharmaceuticals (NASDAQ:CYCC), 3D Systems Corporation (NYSE:DDD), PC Connection (NASDAQ:PCCC), Copart (NASDAQ:CPRT), Microsoft Corporation (NASDAQ:MSFT)
Cyclacel Pharma Inc (Nasdaq:CYCC) announced enrollment of 486 patients, continuation to final analysis and recommendations of the independent Data and Safety Monitoring Board (DSMB) of the Company’s Phase 3 SEAMLESS study of oral sapacitabine capsules in acute myeloid leukemia (AML). All patients will continue to be followed up until mature data become available for final…
-
Biotech Bearish Stocks: Cyclacel Pharmaceuticals (NASDAQ:CYCC), Exact Sciences Corporation (NASDAQ:EXAS), Galena Biopharma (NASDAQ:GALE), TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG), Ruthigen (NASDAQ:RTGN)
Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) reported recommendations of the independent Data and Safety Monitoring Board (DSMB) of the company’s Phase 3 SEAMLESS study of oral sapacitabine capsules in acute myeloid leukemia, or AML. Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) in last trading activity fell -75.98% to close at $0.68. Company weekly performance is -76.77% while its quarterly performance…
-
Stocks Gaining Momentum: Nokia Corporation (ADR) (NYSE:NOK), Advanced Micro Devices (NYSE:AMD), Markit (NASDAQ:MRKT), Cyclacel Pharmaceuticals (NASDAQ:CYCC), PerkinElmer Inc. (NYSE:PKI)
A leader in navigation, mapping and location experiences, Nokia Corporation (ADR) (NYSE:NOK)’s announced that, it has joined hands with leading Chinese language Internet search provider, Baidu Inc (ADR) (NASDAQ:BIDU) to power its new desktop & mobile map services outside of China, all over the world. Nokia Corporation (ADR) (NYSE:NOK) in last trading activity decreased -1.65%…